159 related articles for article (PubMed ID: 33329407)
21. Evaluation of the diagnostic criteria for Cushing's disease in Japan.
Kageyama K; Oki Y; Sakihara S; Nigawara T; Terui K; Suda T
Endocr J; 2013; 60(2):127-35. PubMed ID: 23171704
[TBL] [Abstract][Full Text] [Related]
22. [Corticotroph adenoma].
Guignat L; Assie G; Bertagna X; Bertherat J
Presse Med; 2009 Jan; 38(1):125-32. PubMed ID: 19041214
[TBL] [Abstract][Full Text] [Related]
23. The coexistence of infundibular pituicytoma and Cushing's disease due to pituitary adenoma: A case report.
Gezer E; Selek A; Cetinarslan B; Canturk Z; Tarkun I; Ceylan S
Endocr Regul; 2019 Oct; 53(4):263-267. PubMed ID: 31734654
[TBL] [Abstract][Full Text] [Related]
24. Cyclic Cushing's disease with paradoxical response to dexamethasone.
Checchi S; Brilli L; Guarino E; Ciuoli C; Di Cairano G; Mazzucato P; Pacini F
J Endocrinol Invest; 2005 Sep; 28(8):741-5. PubMed ID: 16277172
[TBL] [Abstract][Full Text] [Related]
25. Cure of Cushing's Disease: Still an Elusive Goal?
Tritos NA
J Clin Endocrinol Metab; 2021 Jan; 106(1):e367-e369. PubMed ID: 32701121
[No Abstract] [Full Text] [Related]
26. Non-invasive Diagnostic Strategy in ACTH-dependent Cushing's Syndrome.
Frete C; Corcuff JB; Kuhn E; Salenave S; Gaye D; Young J; Chanson P; Tabarin A
J Clin Endocrinol Metab; 2020 Oct; 105(10):. PubMed ID: 32594169
[TBL] [Abstract][Full Text] [Related]
27. Successful reduction of ACTH secretion in a case of intractable Cushing's disease with pituitary Crooke's cell adenoma by combined modality therapy including temozolomide.
Tanaka S; Yamamoto M; Morita M; Takeno A; Kanazawa I; Yamaguchi T; Yamada S; Inoshita N; Oki Y; Kurosaki M; Sugimoto T
Endocr J; 2019 Aug; 66(8):701-708. PubMed ID: 31130573
[TBL] [Abstract][Full Text] [Related]
28. Cyclic Cushing's disease with misleading inferior petrosal sinus sampling results during a trough phase.
Bonert V; Bose N; Carmichael JD
Neurosurg Focus; 2015 Feb; 38(2):E7. PubMed ID: 25639325
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and safety of osilodrostat in patients with Cushing's disease (LINC 3): a multicentre phase III study with a double-blind, randomised withdrawal phase.
Pivonello R; Fleseriu M; Newell-Price J; Bertagna X; Findling J; Shimatsu A; Gu F; Auchus R; Leelawattana R; Lee EJ; Kim JH; Lacroix A; Laplanche A; O'Connell P; Tauchmanova L; Pedroncelli AM; Biller BMK;
Lancet Diabetes Endocrinol; 2020 Sep; 8(9):748-761. PubMed ID: 32730798
[TBL] [Abstract][Full Text] [Related]
30. Exaggerated response of adrenocorticotropic hormone to growth hormone-releasing peptide-2 test in Cushing's disease. Case report.
Sakihara S; Kageyama K; Matsumoto A; Ikeda H; Tsushima Y; Naraoka M; Terui K; Nigawara T; Suda T
Neurol Med Chir (Tokyo); 2009 Aug; 49(8):365-9. PubMed ID: 19707004
[TBL] [Abstract][Full Text] [Related]
31. Early recognition of Cushing's disease: a case study.
Iuliano SL; Laws ER
J Am Assoc Nurse Pract; 2013 Aug; 25(8):402-406. PubMed ID: 24170635
[TBL] [Abstract][Full Text] [Related]
32. [Equine Cushing's disease; an update].
Smiet E
Tijdschr Diergeneeskd; 2013 Mar; 138(3):162-5. PubMed ID: 23513997
[TBL] [Abstract][Full Text] [Related]
33. An approach to the evaluation and treatment of Cushing's disease.
Brown RL; Weiss RE
Expert Rev Anticancer Ther; 2006 Sep; 6 Suppl 9():S37-46. PubMed ID: 17004856
[TBL] [Abstract][Full Text] [Related]
34. Cushing's disease.
Bertagna X; Guignat L; Groussin L; Bertherat J
Best Pract Res Clin Endocrinol Metab; 2009 Oct; 23(5):607-23. PubMed ID: 19945026
[TBL] [Abstract][Full Text] [Related]
35. Preclinical Cushing's disease characterized by massive adrenal hyperplasia and hormonal changes after three years of metyrapone therapy.
Ohmori N; Nomura K; Ohmori K; Takano K
Endocr J; 2007 Jun; 54(3):391-7. PubMed ID: 17446657
[TBL] [Abstract][Full Text] [Related]
36. Adrenocortical carcinoma masquerading as Cushing's disease.
Jarial KD; Walia R; Kumar S; Bhansali A
BMJ Case Rep; 2017 Mar; 2017():. PubMed ID: 28356253
[TBL] [Abstract][Full Text] [Related]
37. The Ectopic Adrenocorticotropic Hormone Syndrome: Rarely Easy, Always Challenging.
Hayes AR; Grossman AB
Endocrinol Metab Clin North Am; 2018 Jun; 47(2):409-425. PubMed ID: 29754641
[TBL] [Abstract][Full Text] [Related]
38. Prolactin correction for adequacy of petrosal sinus cannulation may diminish diagnostic accuracy in Cushing's disease.
De Sousa SMC; McCormack AI; McGrath S; Torpy DJ
Clin Endocrinol (Oxf); 2017 Nov; 87(5):515-522. PubMed ID: 28626863
[TBL] [Abstract][Full Text] [Related]
39. The aberrant expression of the gastric inhibitory polypeptide (GIP) receptor in adrenal hyperplasia: does chronic adrenocorticotropin exposure stimulate up-regulation of GIP receptors in Cushing's disease?
Swords FM; Aylwin S; Perry L; Arola J; Grossman AB; Monson JP; Clark AJ
J Clin Endocrinol Metab; 2005 May; 90(5):3009-16. PubMed ID: 15705925
[TBL] [Abstract][Full Text] [Related]
40. Periodic secretion of adrenocorticotropin in a patient with Cushing's disease manifested during pregnancy.
Miyoshi T; Otsuka F; Suzuki J; Inagaki K; Takeda M; Kano Y; Yamashita T; Ogura T; Date I; Tanaka Y; Hashimoto K; Makino H
Endocr J; 2005 Jun; 52(3):287-92. PubMed ID: 16006722
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
